[1] Faculty of Pharmaceutical Medicine. What is pharmaceutical medicine?[EB/OL]. (2019-12-05)[2022-10-09]. https://www.fpm.org.uk/our-specialty/what-is-pharmaceutical-medicine/. [2] 刘雅莉, 谢琪, 刘保延, 等. 临床试验百年历程概述[J]. 中国循证医学杂志, 2016, 16(11): 1241-1249. [3] Anon. IFAPP directory[J]. Int J Pharm Med, 2000, 14(2): 111. [4] IFAPP. The PharmaTrain Syllabus for pharmaceutical medicine/medicines development science (version 2.0) 2018[EB/OL]. (2018-01-01)[2022-10-09]. https://ifapp.org/about/pharmatrain-syllabus. [5] Luscombe D K, Salek M S. An international postgraduate course in pharmaceutical medicine: a 25-year review[J]. Int J Pharm Med, 2001, 15(6): 261-263. [6] Stonier P, Silva H, Lahon H. Pharmaceutical medicine: history, global status, evolution and development[J]. Int J Pharm Med, 2007, 21(4): 253-262. [7] Goldberg A, Smith R N. Pharmaceutical medicine[J]. Lancet, 1985, 1(8426): 447-448. [8] Gabbay F J, Stonier P D. Pharmaceutical medicine: a recognized medical discipline? Have we got the message across?[C]. Ruiz Ferr'an J. Communication in pharmaceutical medicine: a challenge for 1992. Seventh International Conference on Pharmaceutical Medicine, 1990 Sep 23-26; Madrid, Spain. Barcelona: Prous Science Publishers, 1991: 369-374. [9] Morris T, Brostoff J M, Stonier P D, et al. Evolution of ethical principles in the practice of pharmaceutical medicine from a UK perspective[J]. Front Pharmacol, 2020, 10: 1525. [10] ABPI. Innovative Medicines Fund (IMF)[EB/OL]. (2022-03-10)[2022-10-09]. https://www.abpi.org.uk/value-and-access/innovative-medicines-fund-imf/. [11] Criscuolo D. Postgraduate courses in pharmaceutical medicine in Italy[J]. Front Med (Lausanne), 2017, 4: 79. [12] Farmindustria. Indicatori farmaceutici: LUGLIO 2022[EB/OL]. (2022-07-01)[2022-10-09]. https://www.farmindustria.it/app/uploads/2022/07/IndicatoriFarmaceutici2022.pdf. [13] Die Publikationsplattform des Bundesrechts. Verordnung über klinische Versuche mit Ausnahme klinischer Versuche mit Medizinprodukten (Verordnung über klinische Versuche; KlinV)[EB/OL]. (2013-06-01)[2022-10-09]. https://www.fedlex.admin.ch/eli/cc/2013/643/de. [14] SIWF. Fortbildungsprogramm (FBP) der Schweizerischen Gesellschaft für Pharmazeutische Medizin (SGPM)[EB/OL]. (2011-07-19)[2022-10-09]. https://siwf.ch/files/pdf18/fbp_pharmazeutische_medizin_d.pdf. [15] Schnetzler G, Bremgartner M F, Straessle R G, et al. Evolution to a competency-based training curriculum for pharmaceutical medicine physicians in Switzerland[J]. Front Pharmacol, 2019, 10: 164. [16] IMI. Innovative Health Initiative[EB/OL]. (2021-12-15)[2022-10-09]. https://www.imi.europa.eu/about-imi/innovative-health-initiative. [17] IMI. Pharmatrain: pharmaceutical medicine training programme[EB/OL]. (2015-01-31)[2022-10-09]. https://www.imi.europa.eu/projects-results/project-factsheets/pharmatrain. [18] Anon. The PharmaTrain Specialist in Medicines Development (SMD)[EB/OL]. (2016-10-01)[2022-10-09]. https://www.pharmatrain.eu/smd-programme-concept. [19] Allen G M, Chisholm O. Postgraduate education in pharmaceutical medicine in Australia: evaluation and evolution to a global program over 20 years[J]. Ther Innov Regul Sci, 2019, 53(5): 654-660. [20] MTPConnect. Overview[EB/OL]. (2022-10-07)[2022-10-09]. https://www.mtpconnect.org.au. [21] MTPConnect. MTPConnect team[EB/OL]. (2022-10-07)[2022-10-09]. https://www.mtpconnect.org.au/Team. |